R. Fräser

7.5k total citations
228 papers, 5.7k citations indexed

About

R. Fräser is a scholar working on Endocrinology, Diabetes and Metabolism, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, R. Fräser has authored 228 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 118 papers in Endocrinology, Diabetes and Metabolism, 57 papers in Pulmonary and Respiratory Medicine and 40 papers in Molecular Biology. Recurrent topics in R. Fräser's work include Hormonal Regulation and Hypertension (106 papers), Adrenal Hormones and Disorders (43 papers) and Electrolyte and hormonal disorders (24 papers). R. Fräser is often cited by papers focused on Hormonal Regulation and Hypertension (106 papers), Adrenal Hormones and Disorders (43 papers) and Electrolyte and hormonal disorders (24 papers). R. Fräser collaborates with scholars based in United Kingdom, United States and Canada. R. Fräser's co-authors include J. J. Brown, A. F. Lever, J. J. Morton, J. I. S. Robertson, David L. Davies, Anthony F. Lever, M. Tree, J. I. S. Robertson, James I. Robertson and J. B. Ferriss and has published in prestigious journals such as The Lancet, Circulation Research and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

R. Fräser

219 papers receiving 5.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R. Fräser United Kingdom	45	2.8k	1.4k	1.3k	1.1k	919	228	5.7k
Anthony F. Lever United Kingdom	42	2.3k 0.8×	3.0k 2.1×	977 0.7×	880 0.8×	1.1k 1.2×	150	6.4k
J. I. S. Robertson United Kingdom	42	1.5k 0.6×	2.4k 1.6×	1.2k 0.9×	654 0.6×	824 0.9×	157	5.1k
W. S. Peart United Kingdom	41	1.3k 0.5×	1.8k 1.2×	921 0.7×	938 0.9×	1.0k 1.1×	202	5.7k
KAORU YOSHINAGA Japan	40	1.7k 0.6×	1.9k 1.3×	846 0.6×	877 0.8×	1.2k 1.3×	524	6.8k
A. F. Lever United Kingdom	39	1.5k 0.5×	1.8k 1.2×	883 0.7×	648 0.6×	727 0.8×	113	4.0k
Harriet P. Dustan United States	42	1.3k 0.5×	3.0k 2.1×	1.1k 0.9×	1.3k 1.1×	571 0.6×	113	6.1k
J. Howard Pratt United States	37	2.1k 0.7×	1.5k 1.0×	502 0.4×	541 0.5×	1.2k 1.3×	114	4.7k
W. Vetter Switzerland	36	1.0k 0.4×	1.1k 0.8×	902 0.7×	1.1k 1.0×	773 0.8×	226	4.2k
Steven A. Atlas United States	45	1.5k 0.5×	4.5k 3.1×	1.3k 1.0×	660 0.6×	2.3k 2.5×	128	7.9k
A Mimran France	40	1.6k 0.6×	3.0k 2.1×	814 0.6×	814 0.7×	593 0.6×	234	5.5k

Countries citing papers authored by R. Fräser

Since Specialization

Citations

This map shows the geographic impact of R. Fräser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Fräser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Fräser more than expected).

Fields of papers citing papers by R. Fräser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Fräser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Fräser. The network helps show where R. Fräser may publish in the future.

Co-authorship network of co-authors of R. Fräser

This figure shows the co-authorship network connecting the top 25 collaborators of R. Fräser. A scholar is included among the top collaborators of R. Fräser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Fräser. R. Fräser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Faure, Emmanuel, Damien Adam, Lijie Liu, et al.. (2023). 74 Intracellular Pseudomonas aeruginosa in cystic fibrosis lung tissues. Journal of Cystic Fibrosis. 22. S39–S39. 1 indexed citations

McKenzie, S., Elaine C. Friel, M Ingram, et al.. (2004). Effect of Variation at the Aldosterone Synthase Locus (CYP11B2) on Adrenal 11-beta hydroxylation: Pilot Data from the MRC BRIGHT Study. 1 indexed citations

Kenyon, Cynthia, Kathryn Nichol, Scott M. MacKenzie, et al.. (2004). Regulation of 11beta-hydroxylase (CYP11B1) and aldosterone synthase (CYP11B2) gene expression in the rat adrenal gland and central nervous system by ACTH and dexamethasone. 3 indexed citations

Millar, Colin, Gillian A. Gray, A Wallace, et al.. (2003). Aldosterone synthase (CYP11B2) and 11beta-hydroxylase (CYP11B1) gene expression in the normal and failing rat heart. 5. 1 indexed citations

Fräser, R., et al.. (1998). Time-course of functional and pathological changes after a single high acute inhalation of chlorine in rats. European Respiratory Journal. 11(4). 922–928. 60 indexed citations

Fräser, R.. (1990). Peripheral metabolism of corticosteroids as a mechanism of potency modulation. Journal of Endocrinology. 125(1). 1–2. 3 indexed citations

Rostand, Stephen G., et al.. (1988). Myocardial calcification and cardiac dysfunction in chronic renal failure1. The American Journal of Medicine. 85. 651–657. 6 indexed citations

Smith, James E., et al.. (1988). In vivo and in vitro studies of the site of inhibitory action of omeprazole on adrenocortical steroidogenesis. European Journal of Clinical Pharmacology. 35(6). 625–629. 24 indexed citations

Hodsman, G P, J. J. Brown, David L. Davies, et al.. (1982). Converting-enzyme inhibitor enalapril (MK421) in treatment of hypertension with renal artery stenosis.. BMJ. 285(6356). 1697–1699. 33 indexed citations

10.

Fräser, R. & Carlos P. Lantos. (1978). 18-Hydroxycorticosterone: A review. Journal of Steroid Biochemistry. 9(3). 273–286. 89 indexed citations

11.

Jj, Brown, et al.. (1976). Effect of blood pressure angiotensin II and aldosterone concentrations during treatment of severe hypertension with intravenous labetalol: comparison with propranolol.. Institutional Research Information System (Università degli Studi di Brescia). 3(4 Suppl 3). 799–803. 36 indexed citations

12.

Ferriss, J. B., J. J. Brown, R. Fräser, et al.. (1975). Results of adrenal surgery in patients with hypertension, aldosterone excess, and low plasma renin concentration.. BMJ. 1(5950). 135–138. 65 indexed citations

13.

Kremer, D., R. Fräser, J. J. Brown, et al.. (1973). Amiloride in primary hyperaldosteronism with chronic peptic ulceration.. BMJ. 2(5860). 216–217. 13 indexed citations

14.

Brown, J. J., R. H. Chinn, R. Fräser, et al.. (1973). Recurrent Hyperkalaemia due to Selective Aldosterone Deficiency: Correction by Angiotensin Infusion. BMJ. 1(5854). 650–654. 35 indexed citations

15.

Brown, Justin, R. Fräser, A. F. Lever, & J. I. S. Robertson. (1972). Hypertension with aldosterone excess.. BMJ. 2(5810). 391–396. 22 indexed citations

16.

Brown, J. J., David L. Davies, J. B. Ferriss, et al.. (1972). Comparison of Surgery and Prolonged Spironolactone Therapy in Patients with Hypertension, Aldosterone Excess, and Low Plasma Renin. BMJ. 2(5816). 729–734. 138 indexed citations

17.

Ferriss, J. B., et al.. (1972). Aldosterone excess and adrenal carcinoma.. BMJ. 1(5801). 686.1–686. 10 indexed citations

18.

Brown, J. J., R. H. Chinn, David L. Davies, et al.. (1970). Falsely High Plasma Potassium Values in Patients with Hyperaldosteronism. BMJ. 2(5700). 18–20. 40 indexed citations

19.

Samaan, N. A. & R. Fräser. (1964). Effect of Circulating Antibody to Insulin on Serum Levels of Insulin-like Activity in Rats, Guinea-pigs, and a Diabetic Patient. BMJ. 2(5407). 482–485. 7 indexed citations

20.

Waugh, Douglas, et al.. (1953). Combined staff rounds of the Royal Victoria Hospital No. 8: regional enteritis.. PubMed. 68(6). 600–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact